Gen-Probe Inc announces that shareholders of Tepnel Life Sciences, PLC approved the acquisition of Tepnel by Gen-Probe by the requisite majorities at Court and General Meetings held in London earlier today.
More than 99% of Tepnel shareholders voted in favor of the acquisition, which was first announced on January 30, 2009 and is structured as a “scheme of arrangement” under English law. The transaction is expected to close on or around April 8, pending additional court proceedings.
Additional information about today’s meetings can be found on the investor relations section of Tepnel’s Web site.
